LA
BMY icon

Lee Ainslie’s Bristol-Myers Squibb BMY Stock Holding History

Lee Ainslie’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,241
Closed -$2.54M – 686
2021
Q1 		$2.54M Buy
40,241
+17,692
+78% +$1.1M 0.02% 131
2020
Q4 		$1.4M Buy
22,549
+15,382
+215% +$946K 0.02% 184
2020
Q3 		$432K Sell
7,167
-58,206
-89% -$3.5M 0.01% 431
2020
Q2 		$3.84M Sell
65,373
-3,580
-5% -$214K 0.08% 73
2020
Q1 		$3.84M Sell
68,953
-46,300
-40% -$2.83M 0.08% 106
2019
Q4 		$7.4M Sell
115,253
-9,259
-7% -$530K 0.11% 83
2019
Q3 		$6.31M Buy
124,512
+3,512
+3% +$165K 0.09% 98
2019
Q2 		$5.49M Sell
121,000
-17,060
-12% -$795K 0.08% 143
2019
Q1 		$6.59M Buy
+138,060
New +$6.88M 0.09% 137
2018
Q4 		– Sell
-148,610
Closed -$9.23M – 262
2018
Q3 		$9.23M Buy
+148,610
New +$8.82M 0.11% 83

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Lee Ainslie's BMY Position: Q2 2021 in Review

Lee Ainslie sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 40,241 shares — an estimated $2.54M sold.

Lee Ainslie first reported a position in BMY in Q3 2018 and held it in 10 quarters. The position peaked at $9.23M in Q3 2018. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Lee Ainslie reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Lee Ainslie sold 40,241 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.54M.
  • Lee Ainslie first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 10 quarters.
  • Lee Ainslie's Bristol-Myers Squibb position peaked at $9.23M in Q3 2018.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.